1. Introduction {#sec1}
===============

The term interstitial keratitis refers to non-ulcerating inflammation of the corneal stroma without prior involvement of either the epithelium or the endothelium.[@bib1] It is an immune-mediated process thought to be caused by a cellular and humoral response against antigens in the corneal stroma, residual infectious antigens or both.[@bib1] This intralamellar infiltration of lymphocytes is clinically seen as nummular stromal infiltrates.[@bib1] When longstanding, interstitial keratitis leads to corneal stromal neovascularization.

The differential diagnosis of interstitial keratitis includes both infectious and inflammatory etiologies. Congenital syphilis, Lyme disease, tuberculosis, herpes simplex and varicella zoster virus are the major infectious causes, while sarcoidosis, rheumatoid arthritis, Sjogren\'s syndrome, inflammatory bowel disease, polyangiitis with granulomatosis, Behçet\'s disease and Cogan\'s syndrome/polyarteritis nodosa constitute the inflammatory ones.[@bib1]

Given the life-threatening nature of several of the above conditions, appropriate and timely work-up is of utmost importance. Herein we describe a case of polyarteritis nodosa (PAN) that presented as bilateral episcleritis and interstitial keratitis along with systemic symptoms.

2. Case report {#sec2}
==============

A 35-year old Greek man living in Germany presented with a two-month history of bilateral injection, photophobia and foreign body sensation. Over the last year and prior to initiation of his ocular symptoms he had an episode of prolonged diarrhea, followed by atrial fibrillation, skin lesions consistent with erythema nodosum ([Fig. 1](#fig1){ref-type="fig"}A) and occasional knee and ankle edema ([Fig. 1](#fig1){ref-type="fig"}B). He also reported recurrent oral ulcers since childhood and a recent genital ulcer.Fig. 1External photograph of the patient\'s right calf reveals (A) multiple non-ulcerated erythematous nodules consistent with erythema nodosum two months prior to presentation, and (B) significant ankle edema two weeks prior to presentation.Fig. 1

Prior treatment regimens with topical antibiotics (polymyxin B, chloramphenicol) and oral acyclovir had failed to improve his symptoms. The patient reported some response to topical corticosteroids with immediate relapse upon their discontinuation. He brought recent records of negative serology for hepatitis B, C and HIV and of a negative rheumatologic work-up that included testing for anti-nuclear antibodies, rheumatoid factor, anti-dsDNA, anti-Smith, anti-Scl-70, anti-centromere, anti-SSA/Ro, anti-SSB/La, anti-Jo-1, anti-U1-RNP and anti-phospholipid antibodies. ACE and lysozyme levels were normal and chest CT was clear.

On presentation, visual acuity was 20/20 in both eyes and intraocular pressures were within normal limits. Slit lamp examination revealed bilateral diffuse episcleral injection ([Fig. 2](#fig2){ref-type="fig"}A) that blanched with topical phenylephrine, small nummular corneal stromal infiltrates and a few fine stellate keratic precipitates ([Fig. 2](#fig2){ref-type="fig"}B). No cells were detected in the anterior chamber. Dilated fundoscopic examination was normal.Fig. 2Slit lamp photograph of the patient\'s right eye reveals (A) diffuse episcleral injection, and (B) small nummular corneal stromal infiltrates at higher magnification.Fig. 2

The diagnosis of bilateral interstitial keratitis and episcleritis was made and a systemic infectious and inflammatory work-up was undertaken. Our patient had an elevated C-reactive protein (CRP) level of 51 mg/L (normal \< 8.0) and an elevated erythrocyte sedimentation rate (ESR) of 123 mm/h (normal \< 22). Serology for syphilis, Lyme disease and testing for tuberculosis with interferon-gamma release assay (IGRA) were all negative. Rheumatoid factor, pANCA, cANCA, HLA-B51, HLA-B27, and pathergy test were also negative. Knee and ankle ultrasounds revealed joint effusions.

Upper endoscopy and colonoscopy were subsequently performed to rule out inflammatory bowel disease. Although the gastrointestinal mucosal lining appeared healthy, random biopsies were taken and revealed segmental non-granulomatous necrotizing transmural inflammation of medium- and small-sized vessels consistent with polyarteritis nodosa (PAN).

The patient received systemic prednisone and was also placed on azathioprine after the histopathologic diagnosis of PAN. Upon self-tapering his steroids and stopping azathioprine, he developed hearing loss and recurrent interstitial keratitis. He was immediately treated with intravenous pulse steroids, which led to symptom resolution within a few days. The diagnosis of Cogan\'s syndrome/PAN was made and the patient has been on azathioprine and a tapering dose of systemic corticosteroids for the past 1.5 years without recurrence.

3. Discussion {#sec3}
=============

Polyarteritis nodosa is an uncommon systemic vasculitis characterized by subacute, chronic, episodic and segmental necrotizing inflammation of medium- and small-sized arteries. Early diagnosis of PAN is crucial as the five-year mortality rate for untreated PAN is close to 90%.[@bib2] Ocular involvement is present in 10--20% of patients with PAN and it usually manifests as retinal or choroidal vasculitis.[@bib2], [@bib3], [@bib4], [@bib5], [@bib6], [@bib7], [@bib8], [@bib9] In the rheumatology literature, a recent retrospective study of 1286 patients with systemic necrotizing vasculitides that were entered into the French Vasculitis Study Group database over a span of 53 years (1955--2008) identified 393 patients diagnosed with PAN as per the 1990 American College of Rheumatology criteria.[@bib3]^,^[@bib10] Forty-two patients (42/393 or 10.7%) had ophthalmologic manifestations at diagnosis with the most common being blurred vision (13/42), retinal exudates (8/42) and conjunctivitis (8/42).[@bib3] "Keratitis" was seen in three patients though the type of keratitis is not specified nor is the co-occurrence of episcleritis, conjunctivitis, uveitis or retinal vasculitis in these patients.

In the ophthalmic literature, we were able to identify only 10 cases of PAN with well-documented anterior segment findings ([Table 1](#tbl1){ref-type="table"}).[@bib6]^,^[@bib11], [@bib12], [@bib13], [@bib14], [@bib15], [@bib16], [@bib17], [@bib18] Only cases with either a definitive histopathologic diagnosis of PAN or fulfilling the 1990 American College of Rheumatology criteria for PAN were included in [Table 1](#tbl1){ref-type="table"}. Cases not confirmed by the aforementioned diagnostic means were excluded.[@bib19], [@bib20], [@bib21] Seven were women and three were men. Median age at diagnosis was 60 years (range, 23 to 84). Ocular manifestations included conjunctival nodules (n = 1)[@bib12] episcleritis (n = 1)[@bib11], episcleritis and dacryoadenitis (n = 1), [@bib14] scleritis (n = 2)[@bib6]^,^[@bib13], peripheral ulcerative keratitis (n = 3)[@bib6]^,^[@bib17], [@bib18], and scleritis and peripheral ulcerative keratitis (n = 2).[@bib15]^,^[@bib16] Five of the seven patients with scleritis and/or peripheral ulcerative keratitis had bilateral involvement.[@bib6]^,^[@bib16], [@bib17], [@bib18] Nine of the ten patients had inflammation solely in the anterior segment, [@bib6]^,^[@bib11]^,^[@bib12]^,^[@bib14], [@bib15], [@bib16], [@bib17], [@bib18] while one patient had severe scleritis that extended from the limbus up to 8 mm posteriorly and secondary exudative retinal detachment.[@bib13] Six patients had presented with ocular manifestations prior to any other systemic signs of the disease.[@bib6]^,^[@bib11]^,^[@bib14]^,^[@bib16], [@bib17], [@bib18] Delay in diagnosis led to the death of four of these six patients due to systemic vasculitic complications several months after ophthalmologic care was originally sought.[@bib11]^,^[@bib14], [@bib15], [@bib16], [@bib17], [@bib18] In three patients diagnosis was made at autopsy[@bib16], [@bib17], [@bib18], in five by biopsy (skin, n = 2; leg muscle, n = 1; skin and conjunctiva, n = 1; lacrimal gland, n = 1)[@bib6]^,^[@bib12], [@bib13], [@bib14] in one by histopathology after enucleation of the involved eye[@bib15], and in one by use of the 1990 American College of Rheumatology criteria for the classification of vasculitides.[@bib11] The ocular disease resulted in loss of vision and eventual enucleation in three patients[@bib13]^,^[@bib15]^,^[@bib18] and bilateral tectonic lamellar keratoplasties followed by optical penetrating keratoplasties in one patient^6^, while four patients maintained good vision after systemic treatment (range, 20/20 to 20/40).[@bib6]^,^[@bib11], [@bib12], [@bib14] pANCA was tested in three patients and found positive in all three of them.[@bib6]^,^[@bib11]^,^[@bib15]Table 1Review of polyarteritis nodosa cases with anterior segment findings in the ophthalmic literature.Table 1AuthorAge (yrs)\
GenderPresenting Sign of Systemic DiseaseOphthalmic ManifestationpANCALethalDiagnosisOcular OutcomeYamamoto et al. (2000)[@bib11]71 MUnilateral episcleritisUnilateral episcleritisPositiveYes1990 American College of Rheumatology Criteria[@bib10]20/20Akova et al. (1993)[@bib6]56 FBilateral scleritis, weight lossBilateral scleritisN/ANoSkin Nodule Biopsy20/40 in both eyes23 FBilateral peripheral ulcerative keratitisBilateral peripheral ulcerative keratitisPositiveNoSkin Nodule Biopsy20/40 and 20/60\
Penetrating keratoplastiesPurcell et al. (1984)[@bib12]72 FHemoptysis, weight loss, weaknessUnilateral conjunctival nodules and iritisN/AYesSkin and Conjunctiva Biopsy20/40Kielar RA (1976)[@bib13]84 MWeight loss, leg painUnilateral scleritis and exudative retinal detachmentN/ANoLeg Muscle BiopsyEnucleation of blind painful eyeMaclure et al. (1968)[@bib14]60 MUnilateral dacryoadenitis, nodular episcleritisUnilateral dacryoadenitis, nodular episcleritisN/AYesLacrimal Gland Biopsy20/30Moore et al. (1966)[@bib15]75 FWeight loss, malaiseUnilateral scleritis and peripheral ulcerative keratitisPositiveYesHistopathology of Enucleated EyeEnucleation after scleral perforationCogan DG (1955)[@bib16]50 FBilateral scleritis and peripheral ulcerative keratitisBilateral scleritis and peripheral ulcerative keratitisN/AYesAutopsyN/AWise et al. (1952)[@bib18]65 FBilateral peripheral ulcerative keratitisBilateral peripheral ulcerative keratitisN/AYesAutopsyEnucleation of blind right eye, Chronic retinal detachment left eyeGoar et al. (1952)[@bib17]31 FFever, weight lossBilateral peripheral ulcerative keratitisN/AYesAutopsyN/A[^1]

To our knowledge, this is the first case of PAN presenting as bilateral episcleritis and interstitial keratitis. Since our patient did not have active skin disease at the time ophthalmologic consultation was sought, diagnosis ended up being established through biopsies of healthy-appearing colonic mucosa during colonoscopy that aimed to rule out inflammatory bowel disease as the cause of the patient\'s ocular signs and symptoms. Notably, though prior cases of PAN with anterior segment findings were pANCA positive (see [Table 1](#tbl1){ref-type="table"}), pANCA was negative in our patient.

Finally, upon self-tapering his steroids and stopping his immunomodulatory therapy, our patient developed recurrent interstitial keratitis and new onset hearing loss as is commonly seen in Cogan\'s syndrome.[@bib22] The inner ear manifestations of Cogan\'s syndrome are Ménière-like attacks consisting of vertigo, tinnitus, and hearing loss. Approximately 70% of the patients diagnosed with Cogan\'s syndrome have an underlying vasculitic disorder with the histopathological findings of Cogan\'s syndrome being very similar to PAN.[@bib23] Thus, it is thought that Cogan\'s syndrome and PAN might constitute the same entity with Cogan\'s syndrome/PAN being a variation of PAN affecting the inner ear and the eye.[@bib22], [@bib23], [@bib24] Τreatment of Cogan\'s syndrome/PAN includes systemic corticosteroids coupled with chronic immunomodulatory therapy to suppress the potentially life-, sight- and hearing-threatening effects of the systemic vasculitis.[@bib23]^,^[@bib25]

4. Conclusion {#sec4}
=============

Though PAN manifestations in the anterior segment are rare, bilateral episcleritis and interstitial keratitis especially when coupled with systemic signs and symptoms should raise suspicion for this autoimmune systemic vasculitis. Early diagnosis of PAN and subsequent initiation of systemic immunosuppression is crucial in preventing the sight-threatening complications of the vasculitis and, more importantly, in substantially improving survival as the five-year mortality rate of untreated PAN is close to 90%.
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The following is the Supplementary data to this article:Multimedia component 1Multimedia component 1

Supplementary data to this article can be found online at <https://doi.org/10.1016/j.ajoc.2020.100619>.

[^1]: M, male; F, female; pANCA, perinuclear anti-neutrophil cytoplasmic antibodies; N/A, test result is unknown (not done or not reported).
